| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | CN1922165A 3-(4-benzyloxyphenyl)propanoic acid derivative |
| 02/28/2007 | CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1922160A Compounds |
| 02/28/2007 | CN1922144A Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 02/28/2007 | CN1922143A Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents |
| 02/28/2007 | CN1922138A Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1921885A Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
| 02/28/2007 | CN1919844A Method for aqueous phase oxo-synthesis of Iansoprazole |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/28/2007 | CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183411 Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor |
| 02/27/2007 | US7183320 For therapy of neoplastic diseases |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183278 (Halo)alkoxy-3-(alkoxy or alkanoyl)-N-alkylene picolinamide; reacting a picolinic acid, ester or acyl halide with a primary amine; agricultural fungicides; rice blast, cucumber anthracnose, powdery mildew of cucumber and wheat leaf rust |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/27/2007 | US7183008 Electroluminescent materials |
| 02/22/2007 | WO2007021955A2 NITRO SUBSTITUTED α-OLEFIN SYNTHESIS CATALYSTS |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020636A1 Printable materials |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007019942A1 Metal complex |
| 02/22/2007 | WO2006059103A3 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 02/22/2007 | US20070043223 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 02/22/2007 | US20070043089 Method of inhibiting angiogenesis |
| 02/22/2007 | US20070043036 2-Pyridone derivatives as neutrophil elastase inhibitors and their use |
| 02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1754700A2 Synthesis of oligoketides |
| 02/21/2007 | EP1754477A2 Hydroxamic acid derivatives as antibacterials |
| 02/21/2007 | EP1753839A1 Polymer light-emitting material and organic light emitting element |
| 02/21/2007 | EP1753721A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 02/21/2007 | EP1753714A2 2-substituted and 4-substituted aryl nitrone compouds |
| 02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
| 02/21/2007 | EP1753429A1 Modulators of muscarinic receptors |
| 02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1361851B1 Primary intermediates for oxidative coloration of hair |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
| 02/21/2007 | CN1918146A Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 02/21/2007 | CN1918134A Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors |
| 02/21/2007 | CN1918132A Method of coloring with capped diazotized compound and coupling component |
| 02/21/2007 | CN1918127A New cyclocompound having 4-pyridylalkylthio group to which sustituted or unsubstituted amino group is introduced |
| 02/21/2007 | CN1918126A Ionic uv-a sunscreens and compositions containing them |
| 02/21/2007 | CN1918125A Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the transport of electrons of the respiratory chain in phytopathogenic fungal organisms |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1918117A Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1916009A Process for preparing amine platinum complexes |
| 02/21/2007 | CN1915976A Method for preparing 5- chlorine -4 hydroxy -2ú¿1óÄú®- pyridone and intermediate |
| 02/21/2007 | CN1915975A Non-linear optic crystal material of coordination polymer of dinicotinic acid |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/20/2007 | US7179941 N-{3-[3-(2-Chloro-4,5-difluorobenzoyl)ureido]-4-methoxyphenyl}acetamide; treating type 2 diabetes |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179915 Reacting an iridium compound or complex of iridium with pyridine or pyrimidine compounds in presence of Lewis Acid in an solvent; such as bis[(2-pyridinyl- kappa N)phenyl- kappa C]mono[2-(2-pyridinyl- kappa N)(4',6'-difluorophenyl- kappa C]iridium(III) |
| 02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
| 02/20/2007 | US7179872 Reversible addition fragmentation chain transfer (RAFT); using dithioesters such as N,N-Dimethyl-s-thiobenzoylthiopropionamide as chain transfer agents; making low polydispersity acrylamide polymers |
| 02/20/2007 | US7179871 Bis-aryliminepyridine MXn complexes comprising a non-symmetrical ligand of formula (I), wherein M is a metal selected from Fe or Co, n is 2 or 3, and X is halide, optionally substituted hydrocarbyl, alkoxide, amide, or |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/20/2007 | US7179816 Chemical derivatives and their application as antitelomerase agents |
| 02/20/2007 | CA2209392C Process for preparing pyridinecarboxylic esters |
| 02/15/2007 | WO2007019259A1 Method of preparation of nitroaminopyridine compounds |
| 02/15/2007 | WO2007019126A2 Method of preparation of azaindole derivatives |
| 02/15/2007 | WO2007018459A1 Therapeutic agents |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007017713A1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof |
| 02/15/2007 | WO2007017577A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 02/15/2007 | WO2007017509A1 Compounds for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017507A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017453A1 Method for producing heteroaromatic alcohols |
| 02/15/2007 | WO2007017450A1 Fungicidal n-[2-(haloalkoxy)phenyl]heteroarylcarboxamides |
| 02/15/2007 | WO2007017267A2 Novel compounds |
| 02/15/2007 | WO2007017179A1 Use of ionic uv-a sunscreens |
| 02/15/2007 | WO2007017095A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 02/15/2007 | WO2006133242A3 Azinone and diazinone v3 inhibitors for depression and stress disorders |
| 02/15/2007 | WO2006076644A3 Heteroaryl sulfonamides and ccr2 |
| 02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 02/15/2007 | US20070037976 Method for producing an optically active nitro compound |
| 02/15/2007 | US20070037858 Hexyl carboxanilides and their use for controlling undesirable micro-organisms |
| 02/15/2007 | US20070037828 Pyrazolopyrimidines |
| 02/15/2007 | US20070037822 Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 02/15/2007 | US20070037812 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis |